BioSpace News Archive

VBI Vaccines Inc. announced that two abstracts featuring data from the Phase 3 clinical program of the Company’s prophylactic 3-antigen hepatitis B vaccine candidate have been accepted for upcoming e-poster presentations at the Global Hepatitis Summit 2020/2021 and the American Diabetes Association’s Virtual 81st Scientific Sessions.

Semi-quantitative antibody testing is the molecular biology technique that quantitates particular antibodies in a sample.

The British Skin Foundation describes a keloid scar as an overgrown scar that spreads beyond the original area of the damaged skin.

The global teleradiology software market is anticipated to witness healthy growth during the forecast period 2021-2031, finds Fact.MR in a study.

The global hemoconcentrators market is projected to exhibit a steady growth owing to the increasing demand for improved healthcare solutions for patients with cardiovascular diseases.

Midatech Pharma PLC, an R&D biotechnology company focused on improving the bio-delivery and biodistribution of medicines, announces breakthrough in vitro data which demonstrate Q-Sphera’s potential to formulate proteins into long-acting injectable products, as well as significant progress across multiple other programmes.

At the June 21-26, 2021 Annual Meeting of the International Society for Stem Cell Research, stem cell biotechnology company Asymmetrex will present data and examples for a new test for evaluation of the potency of tissue stem cell treatments.

Harbour BioMed announced the dosing of the first patient of HBM4003 in patients with advanced non-small cell lung cancer in its open phase I clinical study.

Rancho Santa Fe Bio, Inc., a San Diego, California-based clinical-stage cardiovascular platform company, announced that it has entered into an exclusive worldwide license agreement with Sanofi, a global biopharmaceutical company.

West Texas patients seeking outpatient, surgical treatment for obesity and its related conditions now have a high-quality, cost-effective choice for receiving care at a nationally accredited program that meets the highest standards for patient safety and quality.